Observation of in Vitro Activities and clinical Evaluation Infection on KW-1062

Akira Watanabe; Masako Sasaki; Yukinori Yonemoto; Sonoko Saito; Kotaro Oizumi; Kiyoshi Konno

doi:10.11250/chemotherapy1953.25.1934

Observation of in Vitro Activities and clinical Evaluation Infection on KW-1062

Akira Watanabe, Masako Sasaki, Yukinori Yonemoto, Sonoko Saito, Kotaro Oizumi, Kiyoshi Konno

Research output: Contribution to journal › Article › peer-review

Abstract

In vitro antimicrobial activity and therapeutic effects of KW-1062 on respiratory tract infections were evaluated and the following results were obtained. The MICs of the drug against clinical isolates of Klebsiella pneumoniae were slightly lower than those of DKB and nearly the same as those of GM. The drug was revealed to be less effective than GM or DKB against Pseudomonas aeruginosa. Of 4 cases, treated with the drug, of respiratory tract infections with gram negative bacilli, an excellent bacteriological and clinical effect was observed in one case, but the 3 remaining cases showed negative clinical responses during the periods of the administration of the drug.

Original language	English
Pages (from-to)	1934-1938
Number of pages	5
Journal	Chemotherapy
Volume	25
Issue number	7
DOIs	https://doi.org/10.11250/chemotherapy1953.25.1934
Publication status	Published - 1977 Jan 1

ASJC Scopus subject areas

Pharmacology (medical)
Infectious Diseases
Pharmacology
Drug Discovery
Oncology

Access to Document

10.11250/chemotherapy1953.25.1934

Fingerprint Dive into the research topics of 'Observation of in Vitro Activities and clinical Evaluation Infection on KW-1062'. Together they form a unique fingerprint.

Cite this

@article{ef0d93e4eb574f829005933b5530487b,

title = "Observation of in Vitro Activities and clinical Evaluation Infection on KW-1062",

abstract = "In vitro antimicrobial activity and therapeutic effects of KW-1062 on respiratory tract infections were evaluated and the following results were obtained. The MICs of the drug against clinical isolates of Klebsiella pneumoniae were slightly lower than those of DKB and nearly the same as those of GM. The drug was revealed to be less effective than GM or DKB against Pseudomonas aeruginosa. Of 4 cases, treated with the drug, of respiratory tract infections with gram negative bacilli, an excellent bacteriological and clinical effect was observed in one case, but the 3 remaining cases showed negative clinical responses during the periods of the administration of the drug.",

author = "Akira Watanabe and Masako Sasaki and Yukinori Yonemoto and Sonoko Saito and Kotaro Oizumi and Kiyoshi Konno",

year = "1977",

month = jan,

day = "1",

doi = "10.11250/chemotherapy1953.25.1934",

language = "English",

volume = "25",

pages = "1934--1938",

journal = "CHEMOTHERAPY",

issn = "0009-3165",

number = "7",

}

TY - JOUR

T1 - Observation of in Vitro Activities and clinical Evaluation Infection on KW-1062

AU - Watanabe, Akira

AU - Sasaki, Masako

AU - Yonemoto, Yukinori

AU - Saito, Sonoko

AU - Oizumi, Kotaro

AU - Konno, Kiyoshi

PY - 1977/1/1

Y1 - 1977/1/1

N2 - In vitro antimicrobial activity and therapeutic effects of KW-1062 on respiratory tract infections were evaluated and the following results were obtained. The MICs of the drug against clinical isolates of Klebsiella pneumoniae were slightly lower than those of DKB and nearly the same as those of GM. The drug was revealed to be less effective than GM or DKB against Pseudomonas aeruginosa. Of 4 cases, treated with the drug, of respiratory tract infections with gram negative bacilli, an excellent bacteriological and clinical effect was observed in one case, but the 3 remaining cases showed negative clinical responses during the periods of the administration of the drug.

AB - In vitro antimicrobial activity and therapeutic effects of KW-1062 on respiratory tract infections were evaluated and the following results were obtained. The MICs of the drug against clinical isolates of Klebsiella pneumoniae were slightly lower than those of DKB and nearly the same as those of GM. The drug was revealed to be less effective than GM or DKB against Pseudomonas aeruginosa. Of 4 cases, treated with the drug, of respiratory tract infections with gram negative bacilli, an excellent bacteriological and clinical effect was observed in one case, but the 3 remaining cases showed negative clinical responses during the periods of the administration of the drug.

UR - http://www.scopus.com/inward/record.url?scp=0017694077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017694077&partnerID=8YFLogxK

U2 - 10.11250/chemotherapy1953.25.1934

DO - 10.11250/chemotherapy1953.25.1934

M3 - Article

AN - SCOPUS:0017694077

VL - 25

SP - 1934

EP - 1938

JO - CHEMOTHERAPY

JF - CHEMOTHERAPY

SN - 0009-3165

IS - 7

ER -